SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose

Background COVID-19 vaccines have been recommended to people with multiple sclerosis (pwMS) and, to ensure durable immunity, a third booster dose has been administered in several countries. Data about potential risks associated with the third booster dose in pwMS, such as vaccine-triggered disease e...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neurology 2024-01, Vol.271 (1), p.24-31
Hauptverfasser:	Di Filippo, Massimiliano, Ferraro, Diana, Ragonese, Paolo, Prosperini, Luca, Maniscalco, Giorgia Teresa, Gallo, Antonio, Cavalla, Paola, Lorefice, Lorena, Nociti, Viviana, Di Sabatino, Elena, Clerico, Marinella, Guaschino, Clara, Radaelli, Marta, Fantozzi, Roberta, Buttari, Fabio, Laroni, Alice, Gajofatto, Alberto, Calabrese, Massimiliano, Malucchi, Simona, Paolicelli, Damiano, De Luca, Giovanna, Tomassini, Valentina, Lanzillo, Roberta, Moccia, Marcello, Solaro, Claudio, Cocco, Eleonora, Gasperini, Claudio, Tortorella, Carla
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Viral Chronic Disease COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - adverse effects Humans Immunization, Secondary - adverse effects Medicine Medicine & Public Health mRNA mRNA Vaccines - adverse effects Multiple sclerosis Multiple Sclerosis - complications Neurology Neuroradiology Neurosciences Original Communication Recurrence Retrospective Studies Severe acute respiratory syndrome coronavirus 2 Vaccination - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!